PL2981270T3 - Estry 2-deoksy-monosacharydów o działaniu przeciwproliferacyjnym - Google Patents

Estry 2-deoksy-monosacharydów o działaniu przeciwproliferacyjnym

Info

Publication number
PL2981270T3
PL2981270T3 PL14780343T PL14780343T PL2981270T3 PL 2981270 T3 PL2981270 T3 PL 2981270T3 PL 14780343 T PL14780343 T PL 14780343T PL 14780343 T PL14780343 T PL 14780343T PL 2981270 T3 PL2981270 T3 PL 2981270T3
Authority
PL
Poland
Prior art keywords
deoxy
monosaccharides
esters
proliferative activity
anti proliferative
Prior art date
Application number
PL14780343T
Other languages
English (en)
Inventor
Waldemar Priebe
Marcin Cybulski
Izabela Fokt
Stanislaw Skora
Charles Conrad
Tomothy MADDEN
Original Assignee
Board Of Regents, The University Of Texas System
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Board Of Regents, The University Of Texas System filed Critical Board Of Regents, The University Of Texas System
Publication of PL2981270T3 publication Critical patent/PL2981270T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7024—Esters of saccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
PL14780343T 2013-04-05 2014-04-04 Estry 2-deoksy-monosacharydów o działaniu przeciwproliferacyjnym PL2981270T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361809110P 2013-04-05 2013-04-05
PCT/US2014/032942 WO2014165736A2 (en) 2013-04-05 2014-04-04 Esters of 2-deoxy-monosaccharides with anti proliferative activity
EP14780343.1A EP2981270B1 (en) 2013-04-05 2014-04-04 Esters of 2-deoxy-monosaccharides with anti proliferative activity

Publications (1)

Publication Number Publication Date
PL2981270T3 true PL2981270T3 (pl) 2022-05-09

Family

ID=51659460

Family Applications (1)

Application Number Title Priority Date Filing Date
PL14780343T PL2981270T3 (pl) 2013-04-05 2014-04-04 Estry 2-deoksy-monosacharydów o działaniu przeciwproliferacyjnym

Country Status (7)

Country Link
US (3) US10201554B2 (pl)
EP (2) EP3939595A1 (pl)
JP (1) JP6545660B2 (pl)
ES (1) ES2897699T3 (pl)
HU (1) HUE056881T2 (pl)
PL (1) PL2981270T3 (pl)
WO (1) WO2014165736A2 (pl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3939595A1 (en) 2013-04-05 2022-01-19 Board of Regents, The University of Texas System Esters of 2-deoxy-monosaccharides with anti proliferative activity
EP3876919A4 (en) * 2018-11-09 2023-01-04 RMD Sciences Inc. COMPOSITIONS FOR THE TREATMENT OF CANCER AND OTHER CONDITIONS

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56103197A (en) 1980-01-21 1981-08-18 Wakamoto Pharmaceut Co Ltd Novel d-glucose derivative and antitumor agent containing the same as active constitutent
JPS58167582A (ja) 1982-03-29 1983-10-03 Takeda Chem Ind Ltd 糖ケタ−ルの製造法
US6319695B1 (en) 1991-10-15 2001-11-20 The Scripps Research Insitute Production of fucosylated carbohydrates by enzymatic fucosylation synthesis of sugar nucleotides; and in situ regeneration of GDP-fucose
ES2162078T3 (es) 1995-06-23 2001-12-16 Oxford Glycosciences Uk Ltd Compuestos terapeuticos.
DE19631221C2 (de) 1996-08-02 1999-07-01 Beiersdorf Ag Schaumförmige Lichtschutzzubereitungen mit einem Gehalt an wasserlöslichen Lichtschutzfiltersubstanzen und grenzflächenaktiven Substanzen
EE200200565A (et) 2000-03-31 2004-06-15 Angiogene Pharmaceuticals Ltd. Vaskulaarse kahjustava toimega kombinatsioonravi
US6670330B1 (en) * 2000-05-01 2003-12-30 Theodore J. Lampidis Cancer chemotherapy with 2-deoxy-D-glucose
CA2317305A1 (en) 2000-08-29 2002-02-28 Tassos P. Anastassiades Method of enhancing chondrocyte cell growth and glycosaminoglycan production
CA2487039A1 (en) 2001-06-11 2002-12-19 Transition Therapeutics Inc. Combination therapies using vitamin b12 and interferon for treatment of viral, proliferative and inflammatory diseases
WO2003018598A2 (en) 2001-08-30 2003-03-06 University College Dublin Monosaccharide derivatives
US7001888B2 (en) 2002-03-29 2006-02-21 Threshold Pharmaceuticals, Inc. Compositions and methods for treating cancer
DE10231370B4 (de) 2002-07-11 2006-04-06 Sanofi-Aventis Deutschland Gmbh Thiophenglycosidderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zur Herstellung dieser Arzneimittel
AU2004204778B2 (en) 2003-01-10 2008-05-22 Threshold Pharmaceuticals, Inc. Treatment of cancer with 2-deoxyglucose
CA2431425A1 (en) 2003-06-05 2004-12-05 Angiogene, Inc. Epas1 gene transfer to improve cell therapy
WO2005065721A2 (en) 2003-12-30 2005-07-21 Board Of Regents, The University Of Texas System Use of an anti-inflammatory compound for the reduction of inflammation secondary to the administration of a lipid-nucleic acid complex
WO2006024489A2 (en) 2004-08-30 2006-03-09 Interstitial Therapeutics Methods and compositions for the treatment of cell proliferation
WO2007000882A1 (ja) 2005-06-28 2007-01-04 Pioneer Corporation 妨害波検出装置および妨害波除去装置
EP1991056A4 (en) 2006-02-24 2009-09-02 Univ Miami MANNOSEDERIVATES FOR THE KILLING OF TUMOR CELLS
EP1986660A4 (en) 2006-02-24 2009-08-26 Univ Texas HEXOSE-BASED COMPOUNDS FOR TREATING CANCER
FR2899588B1 (fr) 2006-04-07 2009-02-27 Oreal Utilisation de compose c-glycoside derive de galactose comme agent activateur et regulateur de l'immunite cutanee
US9149489B2 (en) 2006-04-27 2015-10-06 Board Of Regents, University Of Texas System Inhibitors of glycolysis useful in the treatment of brain tumors
WO2009108926A1 (en) 2008-02-29 2009-09-03 Board Of Regents, The University Of Texas System Inhibitors of glycolysis useful in the treatment of brain tumors
EP1881000A1 (en) 2006-07-17 2008-01-23 Institut National De La Sante Et De La Recherche Medicale (Inserm) Conjugates of 2-fluoro-2-deoxy-glucose and their uses as anti cancer agents
WO2008131024A1 (en) 2007-04-17 2008-10-30 Board Of Regents, The University Of Texas System Iodo-hexose compounds useful to treat cancer
JP5677951B2 (ja) * 2008-07-11 2015-02-25 ボード・オブ・リージエンツ，ザ・ユニバーシテイ・オブ・テキサス・システム 抗癌活性を有する２−デオキシ単糖の新規なアセテート
EP2663314A2 (en) * 2011-01-11 2013-11-20 The University of Texas M.D. Anderson Cancer Monosaccharide-based compounds for the treatment of proliferative and inflammatory dermatological diseases
WO2012142615A2 (en) 2011-04-14 2012-10-18 Board Of Regents, The University Of Texas System Auranofin and auranofin analogs useful to treat proliferative disease and disorders
EP3939595A1 (en) 2013-04-05 2022-01-19 Board of Regents, The University of Texas System Esters of 2-deoxy-monosaccharides with anti proliferative activity

Also Published As

Publication number Publication date
WO2014165736A2 (en) 2014-10-09
US11026960B2 (en) 2021-06-08
EP3939595A1 (en) 2022-01-19
JP6545660B2 (ja) 2019-07-17
EP2981270B1 (en) 2021-08-25
WO2014165736A3 (en) 2014-11-27
EP2981270A2 (en) 2016-02-10
EP2981270A4 (en) 2017-01-04
JP2016515627A (ja) 2016-05-30
US10201554B2 (en) 2019-02-12
US20220023326A1 (en) 2022-01-27
US20160184336A1 (en) 2016-06-30
US11925654B2 (en) 2024-03-12
US20190224225A1 (en) 2019-07-25
ES2897699T3 (es) 2022-03-02
HUE056881T2 (hu) 2022-03-28

Similar Documents

Publication Publication Date Title
HK1220929A1 (zh) 自動注射器
HK1218522A1 (zh) 自動注射器
IL243360A0 (en) Methods for regulating the activity of cftr
HK1218401A1 (zh) 自動注射器
PL3080100T3 (pl) Inhibitory lizyno-specyficznej demetylazy-1
EP2970923A4 (en) MUTANTS OF CRE-RECOMBINASE
GB201321123D0 (en) Amplification of circular molecules
HK1218521A1 (zh) 自動注射器
PL2997117T3 (pl) Zastosowanie estru
HK1218523A1 (zh) 自動注射器
IL279291A (en) Morphic forms of hexadecyloxypropyl-phosphonate esters
HK1224307A1 (zh) 原毒素- 變體及其使用方法
EP2951761A4 (en) GRAPHICS OF ACTIVITIES
IL244507B (en) A consequence of an insulin analogue
HK1218400A1 (zh) 自動注射器
HK1218251A1 (zh) 用拉喹莫德治療多發性硬化症
ZA201602831B (en) Use of lactones
GB201321078D0 (en) Syringe assemblies
IL242491B (en) Consequences of glycinamide a-transformed
AP2015008645A0 (en) Methods of handling papaya
PL2981270T3 (pl) Estry 2-deoksy-monosacharydów o działaniu przeciwproliferacyjnym
TWM476829U (en) Structure of grille
IL224699A0 (en) Protection of buildings
HK1220133A1 (zh) 改善微血管完整性的方法
TWM475821U (en) Structure of mosquito-catch